Revlimid and Rash pruritic - a phase IV clinical study of FDA data
Summary:
Rash pruritic is found among people who take Revlimid, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Revlimid and have Rash pruritic. It is created by eHealthMe based on reports of 331,128 people who have side effects when taking Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
331,128 people reported to have side effects when taking Revlimid.
Among them, 2,079 people (0.63%) have Rash pruritic.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 361,207 Revlimid users for its effectiveness, alternative drugs and more.
What is Rash pruritic?
Rash pruritic (redness with itching) is found to be associated with 2,617 drugs and 1,729 conditions by eHealthMe.
Number of Revlimid and Rash pruritic reports submitted per year:
Time on Revlimid when people have Rash pruritic *:
Gender of people who have Rash pruritic when taking Revlimid*:
Age of people who have Rash pruritic when taking Revlimid *:
Common drugs people take besides Revlimid *:
Common side effects people have besides Rash pruritic *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Revlimid and have Rash pruritic?
Check whether Rash pruritic is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Rash pruritic and when was it recovered:
Expand to all the drugs that have ingredients of lenalidomide:
Alternative drugs to, pros and cons of Revlimid:
- Revlimid (361,207 reports)
Common Revlimid side effects:
- Diarrhea: 27,180 reports
- Death: 25,876 reports
- Fatigue (feeling of tiredness): 21,089 reports
- Multiple myeloma (cancer of the plasma cells): 17,070 reports
- Pneumonia: 16,950 reports
- Rashes (redness): 15,559 reports
- Thrombocytopenia (decrease of platelets in blood): 14,033 reports
- Weakness: 9,637 reports
Browse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zRash pruritic treatments and more:
- Rash pruritic (49,930 reports)
COVID vaccines that are related to Rash pruritic:
- Rash pruritic in Moderna COVID Vaccine
- Rash pruritic in Pfizer BioNTech Covid Vaccine
- Rash pruritic in Johnson and Johnson Covid Vaccine
Common drugs associated with Rash pruritic:
- Humira: 4,126 reports
- Enbrel: 3,450 reports
- Prednisone: 2,955 reports
- Methotrexate: 2,552 reports
- Revlimid: 2,079 reports
- Aspirin: 2,027 reports
- Pegasys: 1,504 reports
- Omeprazole: 1,497 reports
- Ribavirin: 1,388 reports
- Pantoprazole: 1,324 reports
All the drugs that are associated with Rash pruritic:
- Rash pruritic (2,617 drugs)
Common conditions associated with Rash pruritic:
- Rheumatoid arthritis: 4,676 reports
- Multiple myeloma: 2,034 reports
- High blood pressure: 2,025 reports
- Multiple sclerosis: 1,648 reports
- Hepatitis c: 1,634 reports
- Psoriasis: 1,620 reports
- Crohn's disease: 1,407 reports
- High blood cholesterol: 1,319 reports
All the conditions that are associated with Rash pruritic:
- Rash pruritic (1,729 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Klonopin and Electromyogram Abnormal - 2 seconds ago
- Nasacort and Hallucination, Visual - 4 seconds ago
- Ranexa and Idiopathic Thrombocytopenic Purpura - 7 seconds ago
- Anzemet and Ear Barotrauma - 15 seconds ago
- Micro-K and Blood Urea Nitrogen/Creatinine Ratio Increased - 20 seconds ago
- Percocet and Hydrocortisone Acetate drug interaction - 21 seconds ago
- Sodium Bicarbonate and Gastrointestinal Necrosis - 25 seconds ago
- Tracrium and Arrhythmias - 30 seconds ago
- Warfarin Sodium and Ketamine Hcl drug interaction - 35 seconds ago
- Promethazine and Garlic drug interaction - 35 seconds ago